CHST10, or Carbohydrate Sulfotransferase 10, does not have established pharmacogenetic interactions with specific drugs. However, it potentially influences drug efficacy and safety in neurological disorders and cancer therapeutics due to its role in modifying glycosaminoglycans and the extracellular matrix, impacting drug delivery and targeting mechanisms.